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Distant brain metastases from oral squamous cell carcinomas (OSCC) are extremely rare. Here we describe a case of a 53-year-old
man with a primary OSCC who referred to the neurosurgical department because of epileptic seizures. MR imaging revealed an
enhancing lesion in the right parietal lobe. A craniotomy with tumor removing was performed. Histopathological examination
verified an invasive, minimally differentiated metastasis of the primary OSCC. The patient refused whole brain radiation therapy
and died from pulmonary metastatic disease 10 months after the neurosurgical intervention without any cerebral recurrence. To
the authors’ knowledge, only two similar cases have been previously reported.
1. Introduction
Remote brainmetastases fromoral squamous cell carcinomas
(OSCC) are an extremely rare occurrence. To date, only
few cases have been reported previously [1, 2]. In contrast,
direct intracranial invasion is not infrequent in patients with
nasopharyngeal carcinoma (NPC) at a locally advanced stage
[3]. Incidence of brain metastases following NPC may be
increasing secondary to advancements in the treatment of
systemic disease and earlier detection bymore sensitive imag-
ing modalities [4]. Most distant metastases from squamous
cell carcinoma (SCC) are reported to occur in the liver,
lungs, and bones [5]. Therefore, preoperative tumor staging
is focussed on these sites (CT scan of the chest, radionuclide
bone scans, and ultrasound of the liver). In the following case
study, we present a patient who developed a histologically
confirmed brain metastasis of OSCC. The patient developed
symptoms from his cerebral metastasis 29 months after the
primary disease was diagnosed.
2. Case Description
A 53-year-old man with a 29-month history of a slowly
enlarging ulcer on the bottom of the right lateral oral cavity
was referred to our Department of Head and Neck surgery.
After biopsy, a radical surgical resection of the tumorwith
supraomohyoid and functional neck dissection in continuity
and reconstruction with a radial forearm free flap was
performed. Histopathological work-up diagnosed a primary
oral squamous cell carcinoma stage T3N3 (Figure 3(a)).
Based on the stage of this diagnosis, adjuvant radiotherapy
was initiated with a total dose of 64Gy delivered in 32
fractions to both sides of the neck and the primary site. A CT
scan revealed bilateral small pulmonary nodules, which were
diagnosed as pulmonary metastases, but the patient declined
chemotherapy. After radiation therapy, he was well and with
stable disease for 26 months. Then, after a 3-week period
of general weakness, he developed epileptic seizures which
initiated further diagnostic work-up.
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Figure 1: Axial (a) and sagittal (b) magnetic resonance scans (T1w with Gd) reveal an enhancing lesion with central necrosis in the right
parietal lobe which is typically located in the cortical/subcortical layer.
(a) (b)
Figure 2: Histological diagnosis of the cerebral metastasis revealed a minimally differentiated squamous cell carcinoma with single horn
pearls, solid growth, pleomorphic nuclei, and numerous mitosis, adjacent to edematous brain tissue with extensive reactive gliosis. H and E
stain.
MR imaging revealed a heterogeneously enhancing lesion
of approximately 2 × 1 cm in the right parietal lobe, typically
located in the cortical/subcortical area (Figure 1).The patient
was now assessed as T3N3M1, and surgical resection of the
suspected brain metastasis was advised. Preoperative com-
puted tomography (CT) of the chest showed progress of the
pulmonarymetastases. A craniotomywas performed, and the
tumor was completely removed judged upon intraoperative
microscopic and postoperativeMR imaging. Histopathologi-
cal examination verified an invasive, minimally differentiated
metastasis of the primary OSCC (Figures 2 and 3(b)–3(d)).
The patient refused whole brain radiation therapy (30Gy)
and died from pulmonary metastatic disease 10 months
after the neurosurgical intervention without any cerebral
recurrence.
3. Discussion
Malignant tumors can metastasize into every part of the
brain. The underlying factors relating to the differential
propensity of primary tumors to metastasize into the brain
remain unknown. OSCC classically metastasizes to cervical
lymph nodes first. The mechanism of spread is probably
lymphatic. Late presentation of distant metastatic disease
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Figure 3: Histology and immunohistochemistry of OSCC, 5𝜇m thick serial sections of both primary tumor and cerebral metastasis were
stainedwithH&E. Immunochemistrywas performedusing an indirect peroxidase systemwith nonbiotinylated polymer secondary antibodies
following the instructions of themanufacturer (MEDAC). Diaminobenzidine (Sigma, brown) is used as a chromogen.Magnification: original
× 20. (a) Primary intermediately differentiated squamous cell carcinoma of the oral cavity with recognizable squamous cell differentiation.
(b) Cerebral metastasis of poorly differentiated squamous cell carcinoma containing few horn pearls (arrow heads) and central necrosis. (c)
Cerebralmetastasis ofOSCC, immunocytochemistry forCK5/6, a cytokeratinmarker indicative for squamous cell carcinomawith completely
positive brown reaction product on the plasmamembrane of nearly all tumor cells. Adjacent brain tissue shows gliosis but remains negative for
CK-5/6 (light blue). (d) Cerebral metastasis of OSCC, immunohistochemistry for EGFR shows strong overexpression with complete staining
of the cell membranes in all vital tumor cells. Note the negative results in remaining brain parenchyma (light blue).
from OSCC is increasingly reported, in particular those
metastases that are most likely the cause of death after
locoregional control of the primary tumor was achieved [6].
It has been suggested that late-occurring metastases may
result from differences in the proliferative potential of a
subgroup of cells in the growth-arrestedmetastatic tumor [7].
Overexpression of epidermal growth factor receptor (EGFR),
as in our case (Figure 3(d)), has been found in various epithe-
lial malignancies, including head and neck squamous cell
carcinoma (HNSCC), and is associated with increased tumor
growth, metastasis, resistance to chemotherapeutic agents,
and poor prognosis [8]. Treatment with EGFR inhibitors
with chemotherapy can significantly down regulate EGFR
expression and inhibit cell growth of HNSCC. Therefore,
EGFR inhibitors are routinely used in the treatment of
HNSCC. Moreover, a recently published retrospective study
with seven HNSCC patients who developed cerebral metas-
tases, demonstrated a correlationwith human papillomavirus
(HPV) in four out of seven cases [2]. The authors concluded
in their work that, due to the potential for developing brain
metastases from HPV-related HNSCC long after curative
therapy, an extended follow-up is needed in this patients’
collective.
In patients with systemic cancer, parenchymal or lep-
tomeningeal metastases can cause epilepsy, and potentially
reversible medical and neurologic deficits can lead to acute
symptomatic seizures [9]. Surgical removal of symptomatic
lesion followed by external adjuvant radiotherapy is con-
sidered the best treatment in patients with single brain
metastases and with systemic disease which is under control
or absent [10].
4. Conclusion
Our understanding of the complex interactions between
metastatic tumor cells and the host environment should
improve. With development in systemic therapy, the inci-
dence of central nervous system metastases has increased
in patients with cancer [11]. The described case confirmed
the previously reported occurrence of cerebral metastases
of OSCC. Both patients have had their primary disease
for longer than 12 months. According to this knowledge, a
brain metastasis should be taken in consideration in case of
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neurological deterioration. Furthermore, we could detect the
known EGFR within a brain metastasis as a critical protein
for survival of epithelial tissues.
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